A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin

Overview of attention for article published in Diabetology & Metabolic Syndrome, July 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 37 publications that cite this research output.

37

The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.

The Effect of SGLT2 Inhibitor on Renal Anemia in Patients with Moderate to Severe Diabetic Kidney Disease

Preprint in Research Square (February 2024)

Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub‐analysis of the DIVERSITY‐CVR study

Article in Diabetes Obesity and Metabolism (May 2023)

Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis

Article in Diabetes and Vascular Disease Research (May 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.